Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
31
Number of overlapping holdings
27.7%
% of IXJ's 113 holdings also in AGNG
37.8%
% of AGNG's 82 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus AGNG)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in AGNG |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.6% | 3.3% | 3.3% |
|
JOHNSON & JOHNSON | 5.5% | 3.0% | 3.0% |
 |
NOVO NORDISK A/S-B | 2.9% | 2.9% | 2.9% |
|
MERCK & CO. INC. | 2.9% | 2.9% | 2.9% |
|
ABBVIE INC | 4.4% | 2.8% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to AGNG
|
ELI LILLY & CO | 6.2% |
|
UNITEDHEALTH GROUP INC | 6.0% |
|
ABBOTT LABORATORIES | 3.3% |
 |
ROCHE HOLDING LTD | 3.2% |
|
NOVARTIS AG | 3.2% |
 |
ASTRAZENECA PLC | 3.0% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
JOHNSON & JOHNSON | 2.5% |
|
THERMO FISHER SCIENTIFIC INC | 2.4% |
|
GILEAD SCIENCES INC | 1.9% |
IXJ Underweight Relative to AGNG
|
WELLTOWER, INC. | -3.1% |
|
ASTRAZENECA PLC-SPONS ADR | -3.0% |
|
ROCHE HOLDING AG-BR | -2.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -2.8% |
 |
UCB SA | -2.5% |
|
VENTAS INC | -2.5% |
|
EDWARDS LIFESCIENCES CORP | -2.5% |
|
ALCON, INC. | -2.5% |
|
REGENERON PHARMACEUTICALS | -2.1% |
|
TERUMO CORP | -2.0% |